<- Go Home
VCA Inc.
VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates in two segments: an animal hospital and a laboratory. The Animal Hospital segment offers general medical and surgical services for companion animals, as well as specialized treatments comprising diagnostic, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology services; and sells related retail and pharmaceutical products. It also provides specialty pet products, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products; and additional services, such as grooming, bathing, and boarding services. In addition, this segment performs various pet wellness programs, such as health examinations, diagnostic testing, routine vaccinations, spaying, neutering, and dental care. As of December 31, 2016, it operated or managed 795 animal hospitals. The Laboratory segment offers testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment, and prevention of diseases and other conditions affecting animals. This segment serves animal hospitals, animal practices, universities, and other government organizations. It operated a network of 61 veterinary diagnostic laboratories. VCA Inc. also sells digital radiography and ultrasound imaging equipment, related computer hardware, software, and ancillary services to the veterinary market, as well as education and training, consulting, and mobile imaging services; and franchises pet services, including dog daycare, overnight boarding, grooming, and other ancillary services at pet care facilities. The company was formerly known as VCA Antech, Inc. and changed its name to VCA Inc. in June 2014. The company was founded in 1986 and is based in Los Angeles, California. As of September 12, 2017, VCA Inc. operates as a subsidiary of Mars, Incorporated.
Market Cap
$7.6B
Volume
1.0M
Cash and Equivalents
$119.1M
EBITDA
$532.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$657.1M
Profit Margin
24.15%
52 Week High
$93.00
52 Week Low
$59.51
Dividend
N/A
Price / Book Value
4.70
Price / Earnings
34.95
Price / Tangible Book Value
-8.74
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$415.1M
Return on Equity
14.03%
Return on Assets
7.73
Cash and Short Term Investments
$119.1M
Debt
$1.4B
Equity
$1.7B
Revenue
$2.7B
Unlevered FCF
$307.2M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium